Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,907.00
Bid: 1,900.00
Ask: 1,902.00
Change: 2.00 (0.10%)
Spread: 2.00 (0.105%)
Open: 1,916.00
High: 1,927.00
Low: 1,898.00
Prev. Close: 1,905.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up - UPDATE

Mon, 22nd Oct 2012 08:19

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept.Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barclays Capital cuts target from 2,550p to 2,360p, overweight rating kept.Alliance Pharma: Investec ups target from 28p to 28.7p, hold rating kept.ASOS: Investec raises target from 2,450p to 2,700p, buy rating kept.Bunzl: Jefferies ups target from 860p to 880p, underperform rating kept.Circle Oil: Investec keeps buy rating and 80p target.Darty: AlphaValue upgrades from reduce to add.Debenhams: Investec raises target from 114p to 122p, buy rating kept.Devro: Panmure Gordon keeps hold rating and 320p target; Investec keeps buy rating and 355p target.Dixons: AlphaValue upgrades from add to buy.e-Therapeutics: Panmure Gordon cuts target from 76p to 73p, buy rating kept.Fidessa: Merchant Securities cuts target from 1,700p to 1,510p, buy rating kept; Jefferies keeps hold rating and 1,510p target; Investec cuts target from 1,230p to 1,110p, sell rating kept.Hikma Pharmaceuticals: UBS downgrades neutral to sell, 755p unchanged.Jardine Lloyd Thompson: Investec ups target from 692p to 758p, hold rating kept.JD Sports: Seymour Pierce upgrades from hold to buy, target lifted from 800p to 1,000p.Marks & Spencer: Investec keeps sell rating and 275p target.Max Petroleum: Merchant Securities increases target from 4.0p to 4.4p, hold rating kept.Mothercare: HSBC ups target from 180p to 295p, neutral rating kept.Next: Investec keeps hold rating and 3,680p target.Ophir Energy: Jefferies maintains buy rating and 800p target.Paragon Group of Companies: UBS raises target from 254p to 262p, buy rating kept.Petrofac: Liberum Capital downgrades to hold, 1,703p target kept.Provident Financial: JPMorgan Cazenove lifts target from 1,500p to 1,626p, overweight rating kept.RBS: Investec downgrades from hold to sell, 255p target kept.Reckitt Benckiser: Investec maintains hold rating and 3,600p target.Senior: Jefferies maintains buy rating and 223p target; Investec cuts target from 250p to 225p, buy rating kept.Spectris: Panmure Gordon downgrades from buy to hold; Investec upgrades to buy.Spirit Pub: Morgan Stanley ups target from 40p to 55p, underweight rating kept.St James's Place: JPMorgan Cazenove raises target from 417p to 435p, overweight rating kept.Travis Perkins: AlphaValue upgrades from reduce to add.Vodafone: Liberum Capital cuts target from 210p to 205p, buy rating kept.Weir: Panmure Gordon downgrades from buy to hold.Whitbread: Investec keeps sell rating and 1,650p target.William Hill: Barclays Capital ups target from 270p to 280p, underweight rating kept.BC
More News
25 Feb 2021 08:02

UPDATE 2-UK's Hikma misses profit estimate, disappoints on 2021 outlook, share tumbles

* Core operating profit of $566 mln vs consensus of $574 mln* 2021 outlook weaker than analyst expectation* Shares drop nearly 7% (Recasts, adds shares, CEO and analyst comments)By Tanishaa Nadkar and Pushkala AripakaFeb 25 (Reuters) - Hikma Pharmac...

Read more
25 Feb 2021 08:01

LONDON MARKET PRE-OPEN: ABF's Primark Loses GBP1.1 Billion In Sales

LONDON MARKET PRE-OPEN: ABF's Primark Loses GBP1.1 Billion In Sales

Read more
18 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
15 Feb 2021 09:40

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

Read more
3 Feb 2021 09:17

UPDATE 2-Healthcare drags FTSE 100 down; Vodafone jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* GlaxoSmithKline slumps on COVID-19 vaccine development* Vodafone gains after earnings beat estimates* Glencore rises after maintaining 2021...

Read more
1 Feb 2021 13:44

Monday broker round-up

(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.

Read more
26 Jan 2021 08:28

TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia

TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
2 Dec 2020 13:11

Wednesday broker round-up

(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.

Read more
24 Nov 2020 13:33

Tuesday broker round-up

(Sharecast News) - Glencore: Jefferies upgrades to buy with a target price of 250p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.